|
|
Exchange: |
N/A |
Security
Type: |
Common |
Shares
Out: |
90,000,000 |
Market
Cap: |
1.70(B) |
Last
Volume: |
0 |
Avg
Vol: |
0 |
52
Week Range: |
$18.88 - $18.88 |
|
Level
I Sector: |
N/A |
Level
II Sector: |
N/A |
Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
0 |
Total Buy Value |
$0 |
$0 |
$0 |
$0 |
Total People Bought |
0 |
0 |
0 |
0 |
Total Buy Transactions |
0 |
0 |
0 |
0 |
Total Shares Sold |
0 |
0 |
0 |
0 |
Total Sell Value |
$0 |
$0 |
$0 |
$0 |
Total People Sold |
0 |
0 |
0 |
0 |
Total Sell Transactions |
0 |
0 |
0 |
0 |
End Date |
2023-12-28 |
2023-09-26 |
2023-03-28 |
2022-03-28 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Hassler Randal |
EVP, Pharmaceutical Ops. |
|
2019-10-22 |
4 |
D |
$18.00 |
$356,040 |
D/D |
(19,780) |
0 |
|
- |
|
Hassler Randal |
EVP, Pharmaceutical Ops. |
|
2019-10-22 |
4 |
A |
$0.00 |
$0 |
D/D |
14,346 |
19,780 |
|
- |
|
H Lundbeck A S |
10% Owner |
|
2019-10-22 |
4 |
B |
$0.00 |
$0 |
I/I |
85,923,561 |
0 |
1.42 |
- |
|
Green Jeremy |
Director |
|
2019-10-22 |
4 |
D |
$0.00 |
$0 |
I/I |
(8,244,896) |
0 |
|
- |
|
Lavelle Erin |
Chief Operating Officer |
|
2019-10-22 |
4 |
D |
$18.00 |
$289,656 |
D/D |
(16,092) |
0 |
|
- |
|
Lavelle Erin |
Chief Operating Officer |
|
2019-10-22 |
4 |
A |
$0.00 |
$0 |
D/D |
11,684 |
16,092 |
|
- |
|
Streck Paul |
Chief Medical Officer |
|
2019-10-22 |
4 |
D |
$18.00 |
$25,020 |
D/D |
(1,390) |
0 |
|
- |
|
Bucher James B |
EVP & General Counsel |
|
2019-10-22 |
4 |
D |
$18.00 |
$498,186 |
D/D |
(27,677) |
0 |
|
- |
|
Bucher James B |
EVP & General Counsel |
|
2019-10-22 |
4 |
A |
$0.00 |
$0 |
D/D |
15,619 |
27,677 |
|
- |
|
Siegall Clay B |
Director |
|
2019-10-22 |
4 |
D |
$18.00 |
$570,852 |
D/D |
(31,714) |
0 |
|
- |
|
Montgomery Alan Bruce |
Director |
|
2019-10-22 |
4 |
D |
$18.00 |
$173,304 |
D/D |
(9,628) |
0 |
|
- |
|
Smith Jeffrey T L |
Managing Director |
|
2019-10-22 |
4 |
D |
$18.00 |
$387,036 |
D/D |
(21,502) |
0 |
|
- |
|
Smith Jeffrey T L |
Managing Director |
|
2019-10-22 |
4 |
A |
$0.00 |
$0 |
D/D |
16,230 |
21,502 |
|
- |
|
Yarno Wendy L |
Director |
|
2019-10-22 |
4 |
D |
$18.00 |
$90,000 |
D/D |
(5,000) |
0 |
|
- |
|
Streck Paul |
Chief Medical Officer |
|
2019-10-11 |
4 |
A |
$9.20 |
$12,788 |
D/D |
1,390 |
1,390 |
|
- |
|
Bucher James B |
EVP & General Counsel |
|
2019-10-11 |
4 |
A |
$9.20 |
$8,317 |
D/D |
904 |
12,058 |
|
- |
|
Smith Jeffrey T L |
Managing Director |
|
2019-09-16 |
4 |
AS |
$18.44 |
$603,504 |
D/D |
(32,728) |
5,272 |
|
- |
|
Smith Jeffrey T L |
Managing Director |
|
2019-09-16 |
4 |
OE |
$3.47 |
$135,902 |
D/D |
32,728 |
38,000 |
|
- |
|
Bucher James B |
EVP & General Counsel |
|
2019-05-31 |
4 |
A |
$9.20 |
$12,370 |
D/D |
1,345 |
11,154 |
|
- |
|
Smith Jeffrey T L |
Managing Director |
|
2019-04-25 |
4 |
D |
$13.73 |
$66,526 |
D/D |
(4,847) |
5,272 |
|
- |
|
Hassler Randal |
EVP, Pharmaceutical Ops. |
|
2019-04-25 |
4 |
AS |
$13.85 |
$24,067 |
D/D |
(1,738) |
5,434 |
|
- |
|
Benedict Larry |
EVP and PAO |
|
2019-04-25 |
4 |
AS |
$13.65 |
$23,662 |
D/D |
(1,734) |
39,728 |
|
- |
|
Lavelle Erin |
Chief Operating Officer |
|
2019-04-25 |
4 |
AS |
$13.67 |
$19,599 |
D/D |
(1,434) |
4,408 |
|
- |
|
Bucher James B |
EVP & General Counsel |
|
2019-04-25 |
4 |
AS |
$13.85 |
$26,281 |
D/D |
(1,897) |
9,809 |
|
- |
|
Smith Jeffrey T L |
Managing Director |
|
2019-04-23 |
4 |
A |
$0.00 |
$0 |
D/D |
9,288 |
10,119 |
|
- |
|
296 Records found
|
|
Page 1 of 12 |
|
|